- Tytuł:
-
Pemafibrate suppresses NLRP3 inflammasome activation in the
liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy. - Autorzy:
- Źródło:
- Scientific reports [Sci Rep] 2022 Feb 22; Vol. 12 (1), pp. 2996. Date of Electronic Publication: 2022 Feb 22.
- Typ publikacji:
- Journal Article; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Benzoxazoles/*pharmacology
Butyrates/*pharmacology
Cardiomyopathies/*etiology
Cardiomyopathies/*metabolism
Inflammasomes/*metabolismLiver /*metabolism
Myocardium/*metabolism
NLR Family, Pyrin Domain-Containing 3 Protein/*metabolism
Non-alcoholic FattyLiver Disease/*etiology
Non-alcoholic FattyLiver Disease/*metabolism
Animals ; Benzoxazoles/administration & dosage ; Butyrates/administration & dosage ; Cardiomyopathies/drug therapy ; Diet, High-Fat/adverse effects ; Dietary Carbohydrates/adverse effects ; Disease Models, Animal ; Gene Expression/drug effects ; Gene Expression/genetics ; Inflammasomes/genetics ; Male ; Mice, Inbred C57BL ; NLR Family, Pyrin Domain-Containing 3 Protein/genetics ; Non-alcoholic FattyLiver Disease/drug therapy ; Mice
Czasopismo naukowe